Joint Know definition

Joint Know. How” 5 Section 1.31 “Joint Patent Rights” 6 Section 1.32 “Joint Technology” 6 Section 1.33 “Know-How” 6 Section 1.34 “Laws” 6 Section 1.35 “Licensed Compound” 6
Joint Know. How” 7 1.51. “Joint Patents” 7 1.52. “Joint Technology” 7 1.53. “Key Development Studies” 7 1.54. “Knowable Patent” 7 1.55. “Launch Indication(s)” 7 1.56. “Licensed Products” 7 1.57. “Lilly” 8 1.58. “Lilly License” 8 1.59. “Lilly Patent” 8 1.60. “Losses” 8 1.61. “MAA” 8 1.62. “Major Market Countries” 8 1.63. “Manufacturing Information” 8 1.64. “Manufacturing Plan” 8 1.65. “Marketing Plan” 8 1.66. “Marketing Plan Trigger Event” 8 1.67. “Medical Affairs Studies” 8 1.68. “NDA” 8 1.69. “Net Sales” 8 1.70. “Other Licensee” 9 1.71. “Other Licensee Data” 9 1.72. “Patent” 10 1.73. “Price Approval” 10 1.74. “Primary Endpoint” 10 1.75. “Reasonable Buyer” 10 1.76. “Reciprocating Licensee” 11 1.77. “Regulatory Approval” 11 1.78. “Regulatory Authority” 11 1.79. “Regulatory Plan” 11 1.80. “Replacement Indication” 11 1.81. “Replacement Indication Study” 11 1.82. “Replacement Study” 11 1.83. “Required Study” 11 1.84. “Restricted Period” 11 1.85. “Royalty Rate” 11 1.86. “Stock Purchase Agreement” 11 * CONFIDENTIAL TREATMENT REQUESTED: MATERIAL HAS BEEN OMITTED AND FILED WITH THE COMMISSION 1.87. “Supply Agreement” 11 1.88. “Term” 11 1.89. “Territory” 12 1.90. “Territory Specific Studies” 12 1.91. “Third Party” 12 1.92. “Third Party Infringement Claim” 12 1.93. “Transfer Price” 12 1.94. “Unlicensed Product” 12 1.95. “Unlicensed Sales Threshold” 12 1.96. “Valid Claim” 12
Joint Know. How” 7.1.5 “Joint Patents” 7.1.5 “LIBOR” 6.7 “Losses” 12.1 “Markings” 4.4.2 “Merger Party” 13.4.2 “NDA” 1.20 “Non-Breaching Party” 13.2.1 “Notified Party” 13.2.1

Examples of Joint Know in a sentence

  • Subject to the terms and conditions of this Agreement, IAVI hereby grants to TGC a non-exclusive, sublicenseable right and license under the Joint Know How and Joint Patent Rights Controlled by IAVI which are [*] for TGC to make, have made, use, sell, offer for sale and import any non-AAV product worldwide.

  • Subject to the terms and conditions of this Agreement including Sections 5.1.3, 5.7, each of CRI, CHOP and TGC hereby grant to IAVI a [*] license under the Joint Know How Controlled by CRI, CHOP and TGC respectively to make, have made, use, sell, offer for sale and import any IAVI Vaccine for the Developing World.

  • If, after that date, IAVI Know How, Joint Know How owned by IAVI but not TGC or TGC Know How funded by IAVI during the Development Period is used by TGC or its sublicensees in the Development, Manufacture or Commercialization of a TGC Other Vaccine, IAVI will agree to a reasonable reduction in the TGC Other Royalty after consultation with the other Parties, which will be paid by TGC to IAVI on a country by country basis, until twelve (12) years from the initial receipt of TGC Royalty Revenue.

  • During the term of this Agreement, CHOP shall not exercise, license or sublicense any rights of CHOP in or under any Joint Patent Right, any CHOP Patent Right, any Joint Know How, or any CHOP Know How that would be inconsistent with the rights and licenses granted under this Agreement other than, and only to the extent necessary, to assist CHOP to fulfill CHOP’s obligations under the terms and conditions of this Agreement.

  • The Parties shall jointly own any Joint Patent Rights, Joint Inventions and Joint Know How.

  • Each Party acknowledges, represents, warrants and agrees that no Joint Know- How (including Collaboration Licensed Product Know-How) and no Joint Patents (including Collaboration Licensed Product Patents) were conceived, discovered, developed or otherwise made under the Agreement.

  • As of the Effective Date, IAVI has not utilized, or granted a right or license to any Third Party of any Joint Patent Right or Joint Know How for any other purpose other than the Development, Manufacture or Commercialization of an IAVI Vaccine, and IAVI has not utilized, or granted a right or license to any Third Party of any IAVI Know How or IAVI Patent Rights, for any AAV product other than the IAVI Vaccine.

  • During the term of this Agreement, CRI shall not exercise, license or sublicense any rights of CRI in or under any Joint Patent Right, any CRI Patent Right, any Joint Know How, or any CRI Know How that would be inconsistent with the rights and licenses granted under this Agreement other than, and only to the extent necessary, to assist CRI to fulfill CRI’s obligations under the terms and conditions of this Agreement.

  • During the term of this Agreement, IAVI shall not exercise, license or sublicense any rights of IAVI in or under any Joint Patent Right, any IAVI Patent Right, any Joint Know How, or any IAVI Know How that would be inconsistent with the rights and licenses granted under this Agreement other than, and only to the extent necessary, to assist IAVI to fulfill its obligations under the terms and conditions of this Agreement.

  • CHOP shall have no obligation to provide CHOP Know How or Joint Know How other than pursuant to Sections 3.4.2(iv), 9.6.1 and 9.6.5.


More Definitions of Joint Know

Joint Know. How shall mean any Know-How that is developed or acquired jointly by the Parties in connection with their collaborative activities pursuant to this Agreement, including Joint Inventions.
Joint Know. How shall mean any Know-How that is developed or acquired jointly by the Parties during the R&D Term, including Compound/Device Inventions and Other Joint Inventions, but excluding Compound Inventions, Device Inventions and Other Sole Inventions.

Related to Joint Know

  • Joint Know-How has the meaning set forth in Section 8.1.2.

  • Program Know-How which means any and all Know-How that is created, conceived, discovered, first generated, invented, first made or first reduced to practice, in each case (i) by or on behalf of [***], (ii) by or on behalf of [***] or (iii) by or on behalf of [***], but expressly excluding any Joint Program Know-How.

  • Collaboration Know-How means all Know-How and Materials discovered, created, conceived, developed or reduced to practice in the course of performing activities under the Collaboration Program (whether solely by one Party or jointly by the Parties, in each case with their Affiliates or any Third Parties or any employees, consultants or agents of any of the foregoing which perform activities under the Collaboration Program).

  • Product Know-How means, as owned, licensed or controlled by Seller and exclusively related to the Product Business, including as developed in connection with the Clinical Trials, the research and development information, validation methods and procedures, unpatented inventions, know-how, trade secrets, technical or other data or information, or other materials, methods, procedures, processes, materials, developments or technology, including all biological, chemical, clinical, manufacturing and other information or data, other than such know-how which is or becomes the subject of a patent or of a provisional or filed patent application.

  • Licensed Know-How means any and all unpatented and/or non-patentable technical data, documents, materials, samples and other information and know‐how that is Controlled by LICENSOR or any of its Affiliates as of the Effective Date or thereafter during the Term that relates to, or is otherwise reasonably necessary or reasonably useful for, the use, Development, manufacture, or Commercialization of the Product. Licensed Know-How shall not include Licensed Patents.